 |
answer text |
<p>The Government relies on competition to drive down prices of generic medicines
such as antibiotics. This has led to some of the lowest prices in Europe. Freedom
of pricing enables supplies to put prices up quickly to ensure we maintain continuity
of supply despite increasing prices within the global market. In secondary care, tendering
for antibiotics on a frequent basis ensures best value and supply resilience is optimised.</p><p>No
supplier should use the current situation as an opportunity to exploit the National
Health Service. Where companies are found to be abusing their dominant position by
charging excessive and unfair prices, the Competition and Markets Authority (CMA)
can take action against businesses and individuals engaged in anti-competitive conduct.
The CMA is working to establish the facts of what is currently happening in the antibiotic
market. They stand ready to take action if there is evidence of anti-competitive behaviour
that breaks the law.</p>
|
 |
